Baird Reiterates Outperform Rating on Longboard Pharmaceuticals Inc (LBPH)

September 6, 2024 7:10 AM EDT Send to a Friend
Baird analyst Joel Beatty reiterated an Outperform rating and $60.00 price target on Longboard Pharmaceuticals Inc (NASDAQ: LBPH).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login